Enhanced prediction of Src Homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome

Molecular and Cellular Proteomics

Volumn 13, Issue 7, 2014, Pages 1705-1723

  Leung, Kin K ^a   Hause Jr , Ronald J ^a,b   Barkinge, John L ^c   Ciaccio, Mark F ^a,d   Chuu, Chih Pin ^e   Jones, Richard B ^a,f  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Medsphere   (United States)

^d Northwestern University   (United States)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f VMRD INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOPEPTIDE; PROTEIN SH2; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR RECEPTOR; AR PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; GAB1 PROTEIN, HUMAN; PHOSPHOTYROSINE; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROSINE;

ALGORITHM; AMINO ACID SEQUENCE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; BINDING SITE; DISSOCIATION CONSTANT; DISULFIDE BOND; ENZYME ACTIVITY; FLUORESCENCE POLARIZATION; HUMAN; PEPTIDE LIBRARY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SRC HOMOLOGY DOMAIN; SURFACE PLASMON RESONANCE; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BINDING SITES; FLUORESCENCE POLARIZATION; HUMANS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TYROSINE;

EID: 84904108296     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.034876     Document Type: Article

References (77)

1. Weinmaster, G., Zoller, M. J., Smith, M., Hinze, E., and Pawson, T. (1984) Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity. Cell 37, 559-568 (Pubitemid 14079050)
2. Weinmaster, G., and Pawson, T. (1986) Protein kinase activity of FSV (Fujinami sarcoma virus) P130gag-fps shows a strict specificity for tyrosine residues. J. Biol. Chem. 261, 328-333 (Pubitemid 16103948)
3. Sadowski, I., Stone, J. C., and Pawson, T. (1986) A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol. Cell. Biol. 6, 4396-4408 (Pubitemid 17217381)
4. Anderson, D., Koch, C. A., Grey, L., Ellis, C., Moran, M.,F., and Pawson, T. (1990) Binding of SH2 domains of phospholipase C(γ)1, GAP, and Src to activated growth factor receptors. Science 250, 979-982 (Pubitemid 120031802)
5. Moran, M. F., Koch, C. A., Anderson, D., Ellis, C., England, L., Martin, G. S., and Pawson, T. (1990) Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. U.S.A. 87, 8622-8626
6. Kazlauskas, A., Ellis, C., Pawson, T., and Cooper, J. A. (1990) Binding of GAP to activated PDGF receptors. Science 247, 1578-1581
7. Mohammadi, M., Honegger, A. M., Rotin, D., Fischer, R., Bellot, F., Li, W., Dionne, C. A., Jaye, M., Rubinstein, M., and Schlessinger, J. (1991) A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-γ1. Mol. Cell. Biol. 11, 5068-5078 (Pubitemid 21895268)
8. Graziani, A., Gramaglia, D., Cantley, L. C., and Comoglio, P. M. (1991) The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J. Biol. Chem. 266, 22087-22090 (Pubitemid 21908617)
9. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. (1991) Oncogenes and signal transduction. Cell 64, 281-302 (Pubitemid 121001255)
10. Zhou, S., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (Pubitemid 23093884)
11. Songyang, Z., and Cantley, L. C. (1995) Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem. Sci 20, 470-475
12. Obenauer, J. C., Cantley, L. C., and Yaffe, M. B. (2003) Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31, 3635-3641 (Pubitemid 37442212)
13. Li, L., Wu, C., Huang, H., Zhang, K., Ga,n J., and Li, S. S. C. (2008) Prediction of phosphotyrosine signaling networks using a scoring matrix-assisted ligand identification approach. Nucleic Acids Res. 36, 3263-3273 (Pubitemid 351858996)
14. Huang, H., Li, L., Wu, C., Schibli, D., Colwill, K., Ma, S., Li, C., Roy, P., Ho, K., Songyang, Z., Pawson, T., Gao, Y., and Li, S. S. C. (2008) Defining the specificity space of the human SRC homology 2 domain. Mol. Cell. Proteomics 7, 768-784 (Pubitemid 351597486)
15. Jones, R. B., Gordus, A., Krall, J. A., and MacBeath, G. (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439, 168-174 (Pubitemid 43083134)
16. Gordus, A., Krall, J. A., Beyer, E. M., Kaushansky, A., Wolf-Yadlin, A., Sevecka, M., Chang, B. H., Rush, J., and MacBeath, G. (2009) Linear combinations of docking affinities explain quantitative differences in RTK signaling. Mol. Syst. Biol. 5, 235
17. Kaushansky, A., Gordus, A., Chang, B., Rush, J., and MacBeath, G. (2008) A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. Mol. Biosyst. 4, 643-653 (Pubitemid 351706308)
18. Liu, B. A., Engelmann, B. W., Jablonowski, K., Higginbotham, K., Stergachis, A. S., and Nash, P. D. (2012) SRC homology 2 domain binding sites in insulin, IGF-1, and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun. Signal. 10.1186/1478-811X-10-27
19. Liu, B. A., Jablonowski, K., Shah, E. E., Engelmann, B. W., Jones, R. B., and Nash, P. D. (2010) SH2 domains recognize contextual peptide sequence information to determine selectivity. Mol. Cell. Proteomics 9, 2391-2404
20. Hause, R. J., Leung, K. K., Barkinge, J. L., Ciaccio, M. F., Chuu, C., and Jones, R. B. (2012) Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. PLoS ONE 7, e44471
21. Robinson, D. R., Wu, Y. M., and Lin, S. F. (2000) The protein tyrosine kinase family of the human genome. Oncogene 19, 5548-5557
22. Ciaccio, M. F., Wagner, J. P., Chuu, C. P., Lauffenburger, D. A., and Jones, R. B. (2010) Systems analysis of EGF receptor signaling dynamics with microWestern arrays. Nat. Meth. 7, 148-155
23. Volinsky, N., and Kholodenko, B. N. (2013) Complexity of receptor tyrosine kinase signal processing. Cold Spring Harb. Perspect. Biol. 5, a009043
24. Guo, A., Villén, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., Wang, Y., MacNeill, J., Mitchell, J., Gygi, S. P., Rush, J., Polakiewicz, R. D., and Comb, M. J. (2008) Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. U.S.A. 105, 692-697 (Pubitemid 351171770)
25. Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C. M., Zhao, X., Christensen, J., Kosaka, T., Holmes, A. J., Rogers, A. M., Cappuzzo, F., Mok, T., Lee, C., Johnson, B. E., Cantley, L. C., and Jänne, P. A. (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316, 1039-1043 (Pubitemid 46799492)
26. Xu, A. M., and Huang, P. H. (2010) Receptor tyrosine kinase coactivation networks in cancer. Cancer Res. 70, 3857-3860
27. Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., Chin, L., and DePinho, R. A. (2007) Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318, 287-290 (Pubitemid 47574858)
28. Hause, R. J., Jr., Leung, K. K., Barkinge, J. L., Ciaccio, M. F., Chuu, C. P., and Jones, R. B. (2012) Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. PLoS ONE 7, e44471
29. Hynes, N. E., and Lane, H. A. (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341-354 (Pubitemid 40637826)
30. Kitamura, Y., and Hirotab, S. (2004) Kit as a human oncogenic tyrosine kinase. Cell. Mol. Life Sci. 61, 2924-2931 (Pubitemid 40104590)
31. Bolanos-Garcia, V. M. (2005) MET meet adaptors: functional and structural implications in downstream signalling mediated by the Met receptor. Mol. Cell. Biochem. 276, 149-157
32. Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K., and Wong, A. J. (1996) A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560-564 (Pubitemid 26049586)
33. Kallin, A., Demoulin, J. B., Nishida, K., Hirano, T., Rönnstrand, L., and Heldin, C. H. (2004) Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor. J. Biol. Chem. 279, 17897-17904 (Pubitemid 38560558)
34. Sachs, M., Brohmann, H., Zechner, D., Müller, T., Hülsken, J., Walther, I., Schaeper, U., Birchmeier, C., and Birchmeier, W. (2000) Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 150, 1375-1384
35. Bonaccorsi, L., Muratori, M., Carloni, V., Marchiani, S., Formigli, L., Forti, G., and Baldi, E. (2004) The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Steroids 69, 549-552 (Pubitemid 39013486)
36. Mahajan, N. P., Liu, Y., Majumder, S., Warren, M. R., Parker, C. E., Mohler, J. L., Earp, H. S., and Whang, Y. E. (2007) Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 104, 8438-8443 (Pubitemid 47175506)
37. Guo, Z., Dai, B., Jiang, T., Xu, K., Xie, Y., Kim, O., Nesheiwat, I., Kong, X., Melamed, J., Handratta, V. D., Njar, V. C., Brodie, A. M., Yu, L. R., Veenstra, T. D., Chen, H., and Qiu, Y. (2006) Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 10, 309-319 (Pubitemid 44512189)
38. Ponzetto, C., Bardelli, A., Maina, F., Longati, P., Panayotou, G., Dhand, R., Waterfield, M. D., and Comoglio, P. M. (1993) A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell. Biol. 13, 4600-4608 (Pubitemid 23220367)
39. Deleted in proof
40. Gual, P., Giordano, S., Anguissola, S., and Comoglio, P.M. (2001) Differential requirement of the last C-terminal tail of Met receptor for cell transformation and invasiveness. Oncogene 20, 5493-5502 (Pubitemid 32889486)
41. Sakkab, D., Lewitzky, M., Posern, G., Schaeper, U., Sachs, M., Birchmeier, W., and Feller, S. M. (2000) Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL. J. Biol. Chem. 275, 10772-10778 (Pubitemid 30212706)
42. Lamorte, L., Kamikura, D., and Park, M. (2000) A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein. Oncogene 19, 5973-5981 (Pubitemid 32039372)
43. Bouscary, D., Lecoq-Lafon, C., Chretien, S., Zompi, S., Fichelson, S., Muller, O., Porteu, F., Dusanter-Fourt, I., Gisselbrecht, S., Mayeux, P., and Lacombe, C. (2001) Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). Oncogene 20, 2197-2204 (Pubitemid 32531277)
44. Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J. P., and Raynal, P. (2005) A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. J. Biol. Chem. 280, 5350-5360 (Pubitemid 40280009)
45. Gual, P., Giordano, S., Williams, T. A., Rocchi, S., Van Obberghen, E., and Comoglio, P. M. (2000) Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene 19, 1509-1518 (Pubitemid 30175672)
46. Yamasaki, S., Nishida, K., Yoshida, Y., Itoh, M., Hibi, M., and Hirano, T. (2003) Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2. Oncogene 22, 1546-1556 (Pubitemid 36390604)
47. Alexander, W. S. (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2, 410-416
48. Deleted in proof
49. Munugalavadla, V., and Kapur, R. (2005) Role of c-Kit and erythropoietin receptor in erythropoiesis. Crit. Rev. Oncol. Hematol. 54, 63-75 (Pubitemid 40387006)
50. Baxter, R. M., Secrist, J. P., Vaillancourt, R. R., and Kazlauskas, A. (1998) Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events. J. Biol. Chem. 273, 17050-17055 (Pubitemid 28311738)
51. Bernard, A., and Kazlauskas, A. (1999) Phosphospecific antibodies reveal temporal regulation of platelet-derived growth factor beta receptor signaling. Exp. Cell Res. 253, 704-712 (Pubitemid 30003132)
52. Rosenkranz, S., DeMali, K. A., Gelderloos, J. A., Bazenet, C., and Kazlauskas, A. (1999) Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J. Biol. Chem. 274, 28335-28343
53. Engel, P., Eck, M. J., and Terhorst, C. (2003) The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 3, 813-821 (Pubitemid 37328659)
54. Roy, A. K., Lavrovsky, Y., Song, C. S., Chen, S., Jung, M. H., Velu, N. K., Bi, B. Y., and Chatterjee, B. (1999) Regulation of androgen action. Vitam. Horm. 55, 309-352
55. Kraus, S., Gioeli, D., Vomastek, T., Gordon, V., and Weber, M. J. (2006) Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res. 66, 11047-11054 (Pubitemid 44877005)
56. Huggins, C., Stevens, R., and Hodges, C. (1941) Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg. 43, 209-223
57. Bonaccorsi, L., Muratori, M., Carloni, V., Zecchi, S., Formigli, L., Forti, G., and Baldi, E. (2003) Androgen receptor and prostate cancer invasion. Int. J. Androl. 26, 21-25 (Pubitemid 36110851)
58. Chuu, C. P., Hiipakka, R. A., Fukuchi, J., Kokontis, J. M., and Liao, S. (2005) Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Res. 65, 2082-2084 (Pubitemid 40490112)
59. Tauchi, T., Feng, G. S., Marshall, M. S., Shen, R., Mantel, C., Pawson, T., and Broxmeyer, H. E. (1994) The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J. Biol. Chem. 269, 25206-25211 (Pubitemid 24311795)
60. Rodriguez, M., Li, S. S., Harper, J. W., and Songyang, Z. (2004) An oriented peptide array library (OPAL) strategy to study protein-protein interactions. J. Biol. Chem. 279, 8802-8807 (Pubitemid 38295938)
61. Deleted in proof
62. Sánchez, I. E., Beltrao, P., Stricher, F., Schymkowitz, J., Ferkinghoff-Borg, J., Rousseau, F., and Serrano, L. (2008) Genome-wide prediction of SH2 domain targets using structural information and the FoldX algorithm. PLoS Comput. Biol. 4, e1000052
63. Deleted in proof
64. Beck, J. R., and Shultz, E. K. (1986) The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch. Pathol. Lab. Med. 110, 13-20 (Pubitemid 16011804)
65. Liaw, A., and Wiener, M. (2002) Classification and regression by random- Forest. R News 2, 18-22
66. Breiman, L. (2001) Random Forests. Mach. Learn. 45, 5-32
67. Deleted in proof
68. Beebe, K. D., Wang, P., Arabaci, G., and Pei, D. (2000) Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library. Biochemistry 39, 13251-13260
69. Sweeney, M. C., Wavreille, A. S., Park, J., Butchar, J. P., Tridandapani, S., and Pei, D. (2005) Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains. Biochemistry 44, 14932-14947 (Pubitemid 41612272)
70. Tinti, M., Kiemer, L., Costa, S., Miller, M. L., Sacco, F., Olsen, J. V., Carducci, M., Paoluzi, S., Langone, F., Workman, C. T., Blom, N., Machida, K., Thompson, C. M., Schutkowski, M., Brunak, S., Mann, M., Mayer, B. J., Castagnoli, L., and Cesareni, G. (2013) The SH2 domain interaction landscape. Cell Reports 3, 1293-1305
71. Liu, B. A., Jablonowski, K., Raina, M., Arcé, M., Pawson, T., and Nash, P. D. (2006) The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol. Cell 22, 851-868
72. Sing, T., Sander, O., Beerenwinkel, N., and Lengauer, T. (2005) ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940-3941 (Pubitemid 41535515)
73. Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G. F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925 (Pubitemid 37493640)
74. Gentile, A., Trusolino, L., and Comoglio, P. M. (2008) The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev, 27, 85-94
75. Jo, M., Stolz, D. B., Esplen, J. E., Dorko, K., Michalopoulos, G. K., and Strom, S. C. (2000) Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J. Biol. Chem. 275, 8806-8811 (Pubitemid 30180235)
76. Jones, R. B. (2013) Do low-affinity ErbB receptor protein interactions represent the base of a cell signaling iceberg? Expert Rev. Proteomics 10, 115-118
77. Kerrien, S., Aranda, B., Breuza, L., Bridge, A., Broackes-Carter, F., Chen, C., Duesbury, M., Dumousseau, M., Feuermann, M., Hinz, U., Jandrasits, C., Jimenez, R. C., Khadake, J., Mahadevan, U., Masson, P., Pedruzzi, I., Pfeiffenberger, E., Porras, P., Raghunath, A., Roechert, B., Orchard, S., and Hermjakob, H. (2012) The IntAct molecular interaction database in 2012. Nucleic Acids Res. 40, D841-D846